Rosen Law Firm Urges Neumora Therapeutics Investors to Protect Their Rights Before April 7 Deadline in Securities Class Action Lawsuit

Sunday 6th of April 2025 21:41:00

NMRA Important Deadline: Rosen Trusted Investor Counsel Encourages Neumora Therapeutics Inc. Investors to Seek Guidance

Chicago, Illinois - Rosen Law Firm, a global investor rights law firm, reminds investors that an important deadline is approaching in the securities class action lawsuit filed on behalf of purchasers of Neumora Therapeutics Inc. (NYSE: NRTH) common stock between April 22, 2021 and April 19, 2022.

On April 22, 2022, the United States District Court for the Central District of California entered an order appointing Rosen Law Firm as lead counsel in the action. The lawsuit alleges that Neumora Therapeutics Inc. and certain of its officers and directors made false and misleading statements to the public during the class period.

Rosen Law Firm is a trusted investor counsel with decades of experience in securities class actions. The firm has secured numerous significant recoveries for investors in cases involving violations of federal securities laws.

The lawsuit alleges that Neumora Therapeutics Inc. and certain of its officers and directors made false and misleading statements to the public during the class period. Specifically, the complaint alleges that the defendants failed to disclose material adverse facts about the company's business, operations, and prospects.

Investors who purchased Neumora Therapeutics Inc. common stock between April 22, 2021 and April 19, 2022, are encouraged to contact Rosen Law Firm to learn more about their rights and potential remedies. The deadline to file a motion to join the action is July 25, 2022.

Rosen Law Firm has a track record of securing significant recoveries for investors in securities class actions. The firm has secured numerous significant recoveries for investors in cases involving violations of federal securities laws.